CPC A61K 47/59 (2017.08) [C08G 81/024 (2013.01)] | 20 Claims |
1. A composition, comprising:
a macromolecular polyacrylamide copolymer excipient with an α-end comprising a ROMP-active norbornene end-group and a co-end comprising a terminal monomer with an end group chosen from:
a hydrogen atom (H); or
a functionalized acrylate with functionality chosen from alkyl, hydroxyl (OH), methyl-polyethylene glycol ((PEG)-CH3), hydroxy-PEG (PEG-OH), carboxylic acid (COOH), and combinations thereof; and
a biological compound non-covalently bound with the macromolecular excipient, wherein the biological compound is chosen from active pharmaceutical ingredients, proteins, polynucleotides, and mixtures and combinations thereof.
|